Hims & Hers falls 8% after Novo's legal threat. Here's the latest [MSNBC.com]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: MSNBC.com
In this articleRafael Henrique | SOPA Images | APThe stock ofHims & HersNovo NordiskThe online teleheath company announced on Thursday plans to launch a cheaper, copycat version ofNovo'sNovo to take legal action.Hims stock spiked as much as 15% on the news in Thursday trading, but quickly pared gains and ended the session down 3.8% at a 12-month low after Novo said the action was "illegal." Shares fell another 6.7% in premarket trading Friday.Hims said it will launch a Wegovy-style pill containing the same active ingredient as the original brand, semaglutide, for as little as $49 for the first month when customers sign up for a subscription. After the first month, the price will rise to $99.That's significantly lower than the $149 Novo Nordisk sells its starting dose for on its direct-to-consumer website NovoCare.Stock Chart IconStock chart iconHims & Hers stock has been volatile over the past year.Hims is launching its pill even though semaglutide has patent protection in the U.S. un
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "sell (d+)" rating to a "hold (c-)" rating.MarketBeat
- TrumpRx: See the 43 drugs available on the Trump administration's new discounted drug site [CBS News]CBS News
- Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore [Yahoo! Finance]Yahoo! Finance
- Hims & Hers shares tick lower after Novo's legal threat [MSNBC.com]MSNBC.com
- Many 2026 Super Bowl ads share a common theme, revealing a truth about America's current mindset By Mae Anderson and The Associated Press By Mae Anderson and The Associated Press February 6, 2026, 2:06 PM ET [Fortune]Fortune
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/5/26 - Form 6-K
- 2/5/26 - Form 6-K
- 2/5/26 - Form 6-K
- NVO's page on the SEC website